Biomarker discovery study design consistent with the receiver-operator characteristic
Computer Methods and Programs in Biomedicine · 2026
DOI: 10.1016/j.cmpb.2025.109215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Computer Methods and Programs in Biomedicine, 2026. Verfasst von Joakim Ekström und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, SE-751 85 Uppsala, Sweden. Hauptthemen laut MEDLINE: ROC Curve, Biomarkers, Research Design, Biomarkers, Tumor. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Vetenskapsrådet, Sjöbergstiftelsen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, SE-751 85 Uppsala, Sweden.
- Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, SE-751 85 Uppsala, Sweden. Electronic address: tobias.sjoblom@igp.uu.se.
Förderung
- Cancerfonden
- Vetenskapsrådet
- Sjöbergstiftelsen
Zitieren
APA
Ekström, J., Stoimenov, I., Åkerrén Ögren, J., & Sjöblom, T. (2026). Biomarker discovery study design consistent with the receiver-operator characteristic. Computer Methods and Programs in Biomedicine. https://doi.org/10.1016/j.cmpb.2025.109215
Vancouver
Ekström J, Stoimenov I, Åkerrén Ögren J, Sjöblom T. Biomarker discovery study design consistent with the receiver-operator characteristic. Computer Methods and Programs in Biomedicine. 2026. doi:10.1016/j.cmpb.2025.109215
BibTeX
@article{Ekstrm2026,
author = {Ekström, Joakim and Stoimenov, Ivaylo and Åkerrén Ögren, Jim and Sjöblom, Tobias},
title = {Biomarker discovery study design consistent with the receiver-operator characteristic},
journal = {Computer Methods and Programs in Biomedicine},
year = {2026},
doi = {10.1016/j.cmpb.2025.109215}
}
EUVIMED